{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T08:40:08Z","timestamp":1781599208294,"version":"3.54.5"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J Trauma Acute Care Surg"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>Traumatic brain injury (TBI) contributes to substantial morbidity and mortality worldwide. Tranexamic acid (TXA) has been shown to reduce mortality in patients with traumatic intracranial hemorrhage (ICH) when given within 2 hours of injury. Although TXA is an antifibrinolytic, most studies have observed no difference in ICH progression; recent studies suggest that TXA may reduce cerebral edema in TBI. Our objective was to determine if prehospital TXA administered within 2 hours of injury is associated with surrogates of cerebral edema in patients with moderate or severe TBI.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS<\/jats:title>\n            <jats:p>We performed a retrospective analysis of a multinational prehospital trial of TXA administered within 2 hours of injury in patients with moderate or severe TBI. Patients with prehospital Glasgow Coma Scale score of &lt;13 and systolic blood pressure of &gt;90 mm Hg were randomized to placebo, 2-g TXA bolus, or 1-g TXA bolus followed by 1 g 8-hour TXA infusion. Patients who received an intracranial pressure (ICP) monitor were selected for analysis. Baseline demographic, injury severity, and infusion characteristics were compared between TXA dosing cohorts. Proportion of hours spent with ICP of &gt;20 mm Hg, cerebral perfusion pressure (CPP) of &lt;60 mm Hg, and need for craniectomy were compared between groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>A total of 108 patients with ICP monitors made up the study population (placebo, n = 31; 1 g + 1 g, n = 38; 2-g bolus, n = 39). No differences were identified in age, sex, Abbreviated Injury Scale head, Glasgow Coma Scale, Injury Severity Score, crystalloid and blood product infused in first 24 hours, Marshall score, ICH, or mortality between the three treatment arms. No differences in proportions of hours in which ICP of &gt;20 mm Hg or CPP of &lt;60 mm Hg were identified between treatment arms; rate of craniectomy was also similar.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>No association could be identified between TXA treatment and ICP elevation, CPP depression, or need for craniectomy. These results question TXA's potential impact on cerebral edema. Further study is needed to confirm this finding based on the exploratory nature and limited number of subjects in this study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>LEVEL OF EVIDENCE<\/jats:title>\n            <jats:p>Therapeutic\/Care Management; Level IV.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ta.0000000000004516","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T05:01:41Z","timestamp":1739163701000},"page":"794-797","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Association between prehospital tranexamic acid and cerebral edema in patients with moderate or severe traumatic brain injury"],"prefix":"10.1097","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3487-7738","authenticated-orcid":false,"given":"William Ian","family":"McKinley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Lazaridis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Hoefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Polcari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Benjamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Rowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,2,10]]},"reference":[{"issue":"1","key":"bib1-20250618","first-page":"56","article-title":"Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990\u20132016: a systematic analysis for the global burden of disease study 2016 [published correction appears in Lancet Neurol. 2021;20(12):e7]","volume":"18","year":"2019","journal-title":"Lancet Neurol"},{"issue":"1","key":"bib2-20250618","first-page":"CD000196","article-title":"Corticosteroids for acute traumatic brain injury","volume":"2005","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"bib3-20250618","first-page":"CD005400","article-title":"Magnesium for acute traumatic brain injury","volume":"4","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"bib4-20250618","first-page":"CD001527","article-title":"Aminosteroids for acute traumatic brain injury","volume":"1999","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"bib5-20250618","first-page":"CD000565","article-title":"Calcium channel blockers for acute traumatic brain injury","volume":"4","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"bib6-20250618","first-page":"CD006686","article-title":"Beta-2 receptor antagonists for acute traumatic brain injury","volume":"2008","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"bib7-20250618","first-page":"158","article-title":"The effect of a new potent antifibrinolytic agent, tranexamic acid","volume":"13","year":"1966","journal-title":"J Jpn Obstet Gynecol Soc"},{"issue":"10210","key":"bib8-20250618","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(19)32233-0","article-title":"Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial","volume":"394","year":"2019","journal-title":"Lancet"},{"issue":"10","key":"bib9-20250618","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jama.2020.8958","article-title":"Effect of out-of-hospital tranexamic acid vs placebo on 6-month functional neurologic outcomes in patients with moderate or severe traumatic brain injury","volume":"324","year":"2020","journal-title":"JAMA"},{"issue":"4","key":"bib10-20250618","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/TA.0000000000004354","article-title":"The effects of prehospital TXA on mortality and neurologic outcomes in patients with traumatic intracranial hemorrhage: a subgroup analysis from the prehospital TXA for TBI trial","volume":"97","year":"2024","journal-title":"J Trauma Acute Care Surg"},{"key":"bib11-20250618","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-227X-13-20","article-title":"Tranexamic acid for patients with traumatic brain injury: a randomized, double-blinded, placebo-controlled trial","volume":"13","year":"2013","journal-title":"BMC Emerg Med"},{"issue":"4","key":"bib12-20250618","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/emermed-2020-210424","article-title":"Effect of tranexamic acid on intracranial haemorrhage and infarction in patients with traumatic brain injury: a pre-planned substudy in a sample of CRASH-3 trial patients","volume":"38","year":"2021","journal-title":"Emerg Med J"},{"issue":"1","key":"bib13-20250618","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/TA.0000000000003971","article-title":"Early posttraumatic brain injury tranexamic acid prevents blood-brain barrier hyperpermeability and improves surrogates of neuroclinical recovery","volume":"95","year":"2023","journal-title":"J Trauma Acute Care Surg"},{"issue":"4","key":"bib14-20250618","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3171\/JNS\/2008\/109\/10\/0678","article-title":"Relationship of \u201cdose\u201d of intracranial hypertension to outcome in severe traumatic brain injury","volume":"109","year":"2008","journal-title":"J Neurosurg"},{"issue":"11","key":"bib15-20250618","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S1474-4422(23)00290-9","article-title":"Intracranial pressure monitoring with and without brain tissue oxygen pressure monitoring for severe traumatic brain injury in France (OXY-TC): an open-label, randomised controlled superiority trial","volume":"22","year":"2023","journal-title":"Lancet Neurol"},{"issue":"26","key":"bib16-20250618","first-page":"2471","article-title":"A trial of intracranial-pressure monitoring in traumatic brain injury [published correction appears in N Engl J Med. 2013 Dec 19;369(25):2465]","volume":"367","year":"2012","journal-title":"N Engl J Med"},{"issue":"7","key":"bib17-20250618","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S1474-4422(21)00138-1","article-title":"Intracranial pressure monitoring in patients with acute brain injury in the intensive care unit (SYNAPSE-ICU): an international, prospective observational cohort study","volume":"20","year":"2021","journal-title":"Lancet Neurol"},{"issue":"11","key":"bib18-20250618","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1097\/CCM.0000000000002619","article-title":"Brain oxygen optimization in severe traumatic brain injury phase-II: a phase II randomized trial","volume":"45","year":"2017","journal-title":"Crit Care Med"},{"key":"bib19-20250618","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3389\/fneur.2020.00959","article-title":"Intracranial pressure monitoring signals after traumatic brain injury: a narrative overview and conceptual data science framework","volume":"11","year":"2020","journal-title":"Front Neurol"}],"container-title":["Journal of Trauma and Acute Care Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TA.0000000000004516","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T06:00:45Z","timestamp":1750226445000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TA.0000000000004516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,10]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ta.0000000000004516","relation":{},"ISSN":["2163-0763","2163-0755"],"issn-type":[{"value":"2163-0763","type":"electronic"},{"value":"2163-0755","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,10]]}}}